[Form 4] Inogen Inc Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Inogen Inc executive Mary E. Wright, the VP and Chief Accounting Officer, reported several equity compensation transactions. On March 1, 2026, multiple restricted stock unit tranches, including 1,755, 2,750 and 3,001 units, were exercised or converted into common stock at no cash cost. She also received common stock grants of 1,500 and 1,351 shares, while 675, 520, 1,058 and 1,155 shares of common stock at $6.10 were withheld to cover tax liabilities on the vesting awards. A separate grant of 8,000 restricted stock units was awarded on February 27, 2026, with vesting over several years subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
7,506 shares exercised/converted
Mixed
13 txns
Insider
Wright Mary E
Role
VP, Chief Accounting Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 1,755 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 2,750 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 3,001 | $0.00 | -- |
| Grant/Award | Common Stock | 1,500 | $6.10 | $9K |
| Exercise | Common Stock | 1,755 | $0.00 | -- |
| Tax Withholding | Common Stock | 675 | $6.10 | $4K |
| Grant/Award | Common Stock | 1,351 | $0.00 | -- |
| Tax Withholding | Common Stock | 520 | $6.10 | $3K |
| Exercise | Common Stock | 2,750 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,058 | $6.10 | $6K |
| Exercise | Common Stock | 3,001 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,155 | $6.10 | $7K |
| Grant/Award | Restricted Stock Unit | 8,000 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Unit — 0 shares (Direct);
Common Stock — 13,680 shares (Direct)
Footnotes (1)
- Shares acquired through the Company's 2014 Employee Stock Purchase Plan. The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026. The reported securities represent shares earned and vested on March 1, 2026 based on achievement of the financial performance conditions for the 2025 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on February 28, 2023. The reported shares were withheld to cover the reporting person's tax withholding liability in connection with the 2023 performance-based restricted stock unit award granted on February 28, 2023 and vested on March 1, 2026. Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date. The restriced stock units were fully vested on March 1, 2026. 1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date. 1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date.
